Terminated PHASE3 INTERVENTIONAL 4-arm NCT00308113

CoQ10 and Prednisone in Non-Ambulatory DMD

PITT0503: Clinical Trial of Coenzyme Q10 and Prednisone in Duchenne Muscular Dystrophy

Sponsor: Cooperative International Neuromuscular Research Group

Updated 7 times since 2017 Last updated: Oct 16, 2013 Started: Apr 30, 2007 Primary completion: Nov 30, 2010 Completion: Nov 30, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

New enrollment has been suspended, currently following previously enrolled participants

A PHASE3 clinical study on Duchenne Muscular Dystrophy, this trial is terminated or withdrawn. The trial is conducted by Cooperative International Neuromuscular Research Group and has accumulated 7 data snapshots since 2007. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE3
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE3
Dec 2021 — Jul 2024 [monthly]

Terminated PHASE3
Jan 2021 — Dec 2021 [monthly]

Terminated PHASE3
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE3

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Terminated PHASE3
Jan 2017 — Feb 2017 [monthly]

Terminated PHASE3

First recorded

Apr 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Cooperative International Neuromuscular Research Group
United States Department of Defense

Data source: Cooperative International Neuromuscular Research Group

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Pittsburgh, United States